Global prevalence and disability burden of brain disorders: Impact of neurological, mental, and substance use disorders.
Salehinejad MA, Fathi Jouzdani A, Bandeira ID, Bender S, Bikson M, Castelo-Branco M, Cohen Kadosh R, Costanzo F, Croarkin PE, Desarkar P, Dyke K, Eickhoff S, Fitzgerald PB, Hartwigsen G, Koenig J, Martino D, Menghini D, Mirfazeli FS, Moliadze V, Nitsche MA, Oberman LM, Siniatchkin M, Vaziri Z, Vicario CM, Vöckel J, Wischnewski M, Wolters CH, Zangen A, Zaehle T, Zomorrodi R, Brunoni AR.
Salehinejad MA, et al. Among authors: oberman lm.
Neurosci Biobehav Rev. 2026 Sep;188:106808. doi: 10.1016/j.neubiorev.2026.106808. Epub 2026 Jun 10.
Neurosci Biobehav Rev. 2026.
PMID: 42269957
Free article.
Review.
Alzheimer's disease/dementias, Parkinson's disease, autism spectrum disorder (ASD), depressive and anxiety disorders, and opioid and drug use disorders showed the largest increases in burden within their respective categories between 2010 and 2021. ...
Alzheimer's disease/dementias, Parkinson's disease, autism spectrum disorder (ASD), depressive and anxiety disorders, and opioid and …